Overview

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

Status:
Recruiting
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
Efficacy and Safety of DWJ1248 with Remdesivir in Severe COVID-19 Patients
Phase:
Phase 3
Details
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Treatments:
Remdesivir